Therapeutic TREM-1 peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9273111
APP PUB NO 20120015867A1
SERIAL NO

13181323

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BRISTOL-MYERS SQUIBB COMPANY;UNIVERSITE DE LORRAINE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Faure, Gilbert Vandoeuvre les Nancy, FR 7 63
Gibot, Sebastien Vandoeuvre les Nancy, FR 10 67
Panina, Paola Milan, IT 11 83
Passini, Nadia Milan, IT 6 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00